Evaluation of primary, accumulated dermal irritability and sensitization of a cream, through the Patch Test_TCI01.2022

Ipclin Instituto de Pesquisa Clínica Integrada Ltda0 个研究点开始时间: 2022年8月10日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Male and female; Age: 18 to 65 years; Phototype: I to IV; Whole skin of the area

•Participants who refuse to participate in the study in question; Revision marks and experimental area that interfere in the evaluation of reactions of reactions; Active dermatoses (local and disseminated) that may interfere with the study results; Pregnant or lactating women; History of drugs for allergic reactions, purchases or products of sensations of intense and topical use: Volunteers with a history of allergies to the material used in the study; Atopy history; Use of vaginal cream; Participants with a history of allergies and products in the category tested; Recent gynecological surgeries; discharges; History of pathologies aggravated or triggered by ultraviolet radiation; Immunodeficiency carriers; Kidney, heart or liver transplants; Forecast of intense sun exposure or tanning session during the period conducting the study; Forecast to take a bath in the sea, swimming pool or sauna during the study; Participants who play sports; Use of the following systemic topical drugs: immunosuppressants, antihistamines, non-steroidal anti-inflammatory drugs, and corticosteroids up to two weeks before selection; Treatment with acidic vitamin A and/or its oral or topical delivery up to 1 month before the start of the study; Forecast before carrying out study 03; Any condition not mentioned above that may, in the opinion of the investigator, carry out an evaluation of the study

发起方

Ipclin Instituto de Pesquisa Clínica Integrada Ltda